CENCORA INC (COR) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:COR - US03073E1055 - Common Stock
COR Key Statistics, Chart & Performance
The current stock price of COR is 344.5 USD. In the past month the price decreased by -5.21%. In the past year, price increased by 48.34%.
COR Latest News, Press Relases and Analysis
COR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 22.49 | 100.66B | ||
| CAH | CARDINAL HEALTH INC | 22.26 | 47.12B | ||
| HSIC | HENRY SCHEIN INC | 15.82 | 8.97B | ||
| AHCO | ADAPTHEALTH CORP | 32.03 | 1.39B | ||
| OMI | OWENS & MINOR INC | 2.29 | 228.18M | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 55.61M |
Related stock screener links
About COR
Company Profile
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 42,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Company Info
CENCORA INC
1 West First Avenue
Conshohocken PENNSYLVANIA 80202 US
CEO: Paul E. Szurek
Employees: 42000
Phone: 16107277000
CENCORA INC / COR FAQ
What does COR do?
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 42,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Can you provide the latest stock price for CENCORA INC?
The current stock price of COR is 344.5 USD. The price increased by 1.09% in the last trading session.
Does CENCORA INC pay dividends?
CENCORA INC (COR) has a dividend yield of 0.71%. The yearly dividend amount is currently 2.25.
How is the ChartMill rating for CENCORA INC?
COR has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Where is CENCORA INC (COR) stock traded?
COR stock is listed on the New York Stock Exchange exchange.
How many employees does CENCORA INC have?
CENCORA INC (COR) currently has 42000 employees.
What is the market capitalization of COR stock?
CENCORA INC (COR) has a market capitalization of 66.83B USD. This makes COR a Large Cap stock.
COR Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to COR. When comparing the yearly performance of all stocks, COR is one of the better performing stocks in the market, outperforming 88.58% of all stocks.
COR Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to COR. COR has an average financial health and profitability rating.
COR Financial Highlights
Over the last trailing twelve months COR reported a non-GAAP Earnings per Share(EPS) of 15.99. The EPS increased by 16.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.48% | ||
| ROA | 2.03% | ||
| ROE | 103.06% | ||
| Debt/Equity | 5 |
COR Forecast & Estimates
21 analysts have analysed COR and the average price target is 391.08 USD. This implies a price increase of 13.52% is expected in the next year compared to the current price of 344.5.
For the next year, analysts expect an EPS growth of 11.56% and a revenue growth 6.08% for COR